What is semaglutide?
Semaglutide is the active ingredient in several different injectable medications such as Wegovy, Ozempic, and Rybelsus. It has been widely used for weight loss and to lower blood sugar levels and reduce the risk of major cardiovascular events such as heart attack or stroke type two diabetes patients.
How does semaglutide work?
Semaglutide is a GLP-1 agonist and works by increasing insulin release in the body by lowering the amount of glucagon released, delaying gastric emptying and reducing appetite. Semaglutide also controls appetite and so helps you reduce the amount of food that you want to eat.
Why choose semaglutide sublingual compounding option?
Many patients would prefer to avoid injections if possible, and there is an extremely low absorption of oral tablets (less than 1 % per the labeling for RYBELSUS®).
For these reasons, prescribers and patients may prefer a patent-pending compounded formulation of Semaglutide for sublingual administration described here.
Pursuant to a prescription from a healthcare provider, this patent-pending compounded formulation is simple to prepare and has two ingredients:
- RYBELSUS® tablets
- SubMagna�
It is important to note that this formula does not venture into the world where violations of molecular patents might occur such as what often may occur with compounded injectable medications.
